Excessive expression of TF occurs in prothrombotic conditions such as sepsis, endotoxemia, systemic lupus erythematosus, atherosclerosis, Crohn's disease, transplant rejection reactions and hemolytic uremic syndrome (HUS) [13], [14], [15], [16], [17], [18]. Here, TF is linked to hemolytic-uremic syndrome.